BSEKerala Ayurveda LtdMediumNeutral
Announced Fri, 26 Sept · 20:30 IST

Proceedings of AGM held on 26th September, 2025

Board & Shareholder Meetings View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Kerala Ayurveda Ltd held its 33rd Annual General Meeting on September 26, 2025, via video conferencing from 12:00 PM to 1:00 PM, attended by 30 members. Chairman Mr. Ramesh Vangal chaired the meeting, with key executives including CEO Vivek Sunder, CFO George K T, and CS Priyanka Gangwar present. Four ordinary resolutions were tabled: (1) adoption of audited standalone and consolidated financial statements for FY ended March 31, 2025, (2) re-appointment of Mr. Kodikannath Jayarajan as director retiring by rotation, (3) ratification of remuneration for cost auditors M/s. SLR & Associates, and (4) appointment of M/s. SVJS & Associates as secretarial auditors for a 5-year term. The Chairman discussed FY25 company performance and addressed shareholder queries. Voting results from remote e-voting and e-voting at the AGM are pending and will be shared with the exchange in due course.

Likely market impact

This is a routine procedural disclosure confirming the AGM was conducted in compliance with regulations. No material business decisions were announced beyond standard items like director re-appointment and auditor ratification, so there is likely minimal direct impact on the stock price. Investors should watch for the upcoming voting results to confirm shareholder approval of the resolutions.